Litcius/Paper detail

Pancreatic involvement due to immune checkpoint inhibitors: a proposed classification

Motaz Ashkar, Shruti Chandra, Santhi Swaroop Vege, Hiroaki Takahashi, Naoki Takahashi, Robert R. McWilliams

2022Cancer Immunology Immunotherapy12 citationsDOIOpen Access PDF

Topics & Concepts

MedicineNivolumabPembrolizumabInternal medicinePancreatic cancerAdverse effectCommon Terminology Criteria for Adverse EventsPancreatitisPancreasAsymptomaticGastroenterologyOncologyCancerImmunotherapyCancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment
Pancreatic involvement due to immune checkpoint inhibitors: a proposed classification | Litcius